FDA Inspection
Centrient Pharmaceuticals India Private LimitedCentrient Pharmaceuticals India Private Limited – FDA Inspection, Jul 1, 2022
Record Details
This FDA Inspection record concerns Centrient Pharmaceuticals India Private Limited, with an inspection on July 1, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 1, 2022
- Product Type
- Drugs
View Company Profile
ID · caf5c630-7068-41c3-92f9-449781b7735b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1175790
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- Warning Letter
Other FDA inspections of Centrient Pharmaceuticals India Private Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 27, 2026 | Not classified | Office of Inspections and Investigations | |
| April 20, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 18, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Centrient Pharmaceuticals India Private Limited
- FDA Inspection 1310126 - 2026-01-27
- FDA Inspection 1050153 - 2018-04-20
- FDA Inspection 954842 - 2015-12-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.